Diego Cadavid

6.2k total citations · 1 hit paper
120 papers, 4.3k citations indexed

About

Diego Cadavid is a scholar working on Pathology and Forensic Medicine, Parasitology and Infectious Diseases. According to data from OpenAlex, Diego Cadavid has authored 120 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pathology and Forensic Medicine, 34 papers in Parasitology and 32 papers in Infectious Diseases. Recurrent topics in Diego Cadavid's work include Multiple Sclerosis Research Studies (49 papers), Vector-borne infectious diseases (34 papers) and Viral Infections and Vectors (31 papers). Diego Cadavid is often cited by papers focused on Multiple Sclerosis Research Studies (49 papers), Vector-borne infectious diseases (34 papers) and Viral Infections and Vectors (31 papers). Diego Cadavid collaborates with scholars based in United States, Germany and Italy. Diego Cadavid's co-authors include Robert W. Motl, Alan G. Barbour, John H. Pula, Brian M. Sandroff, Yvonne C. Learmonth, Andrew R. Pachner, Hernando Mena, Leo Wolansky, Sha Mi and R. Blake Pepinsky and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

Diego Cadavid

118 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis

2013 572 citations Diego Cadavid et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Diego Cadavid United States	34	2.1k	989	903	691	538	120	4.3k
Andrew R. Pachner United States	38	1.3k 0.6×	2.1k 2.1×	1.9k 2.1×	896 1.3×	478 0.9×	135	4.7k
Israel Steiner Israel	39	790 0.4×	844 0.9×	1.2k 1.3×	1.7k 2.4×	394 0.7×	181	5.7k
Wolfgang Kristoferitsch Austria	28	2.1k 1.0×	1.1k 1.2×	1.0k 1.1×	1.7k 2.5×	156 0.3×	71	4.1k
Donald H. Gilden United States	50	1.1k 0.5×	1.1k 1.2×	796 0.9×	1.4k 2.1×	698 1.3×	192	8.6k
Anita Belman United States	33	1.1k 0.5×	559 0.6×	1.3k 1.4×	750 1.1×	222 0.4×	61	3.5k
Sebastian Rauer Germany	30	867 0.4×	404 0.4×	438 0.5×	1.4k 2.0×	256 0.5×	127	2.9k
Gabriele Arendt Germany	29	679 0.3×	201 0.2×	894 1.0×	368 0.5×	764 1.4×	124	3.6k
Bruce A. Cohen United States	46	1.1k 0.5×	71 0.1×	1.9k 2.1×	1.1k 1.6×	989 1.8×	109	7.1k
Gregory A. Dekaban Canada	37	1.7k 0.8×	177 0.2×	188 0.2×	423 0.6×	215 0.4×	144	4.6k
Marjaleena Koskiniemi Finland	38	221 0.1×	476 0.5×	1.2k 1.3×	705 1.0×	286 0.5×	123	4.4k

Countries citing papers authored by Diego Cadavid

Since Specialization

Citations

This map shows the geographic impact of Diego Cadavid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Cadavid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Cadavid more than expected).

Fields of papers citing papers by Diego Cadavid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Cadavid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Cadavid. The network helps show where Diego Cadavid may publish in the future.

Co-authorship network of co-authors of Diego Cadavid

This figure shows the co-authorship network connecting the top 25 collaborators of Diego Cadavid. A scholar is included among the top collaborators of Diego Cadavid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego Cadavid. Diego Cadavid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Petrillo, Jennifer, Laura J. Balcer, Steven Galetta, et al.. (2018). Initial Impairment and Recovery of Vision-Related Functioning in Participants With Acute Optic Neuritis From the RENEW Trial of Opicinumab. Journal of Neuro-Ophthalmology. 39(2). 153–160. 19 indexed citations

Maranzano, Josefina, David A. Rudko, Kunio Nakamura, et al.. (2017). MRI evidence of acute inflammation in leukocortical lesions of patients with early multiple sclerosis. Neurology. 89(7). 714–721. 13 indexed citations

Mellion, Michelle, Keith R. Edwards, Raymond Hupperts, et al.. (2017). Additional Efficacy Analyses from the Phase 2b SYNERGY Study Investigating the Anti-LINGO-1 Monoclonal Antibody Opicinumab for Treatment of Disabling Multiple Sclerosis (P5.337). Neurology. 88(16_supplement). 1 indexed citations

Chen, Shih‐Yin, Farrah Pompilus, Sophie Cleanthous, et al.. (2017). Development of a Gait Module to Complement the 12-item Patient-Reported Multiple Sclerosis Walking Scale (P1.374). Neurology. 88(16_supplement). 1 indexed citations

Chen, Shih‐Yin, Farrah Pompilus, Sophie Cleanthous, et al.. (2017). Patient-Reported Outcome Measurement in Manual Ability for Multiple Sclerosis: Addressing the Targeting Issues of the ABILHAND (P3.364). Neurology. 88(16_supplement). 2 indexed citations

Cadavid, Diego, Alexander Klistorner, Yi Chai, et al.. (2016). Evidence That the Anti-LINGO-1 Monoclonal Antibody BIIB033 Protects Against Multifocal Visual Evoked Potential Amplitude Loss in the Fellow Eye of Subjects with Unilateral Acute Optic Neuritis (I10.009). Neurology. 86(16_supplement). 1 indexed citations

Mikol, Daniel D., J. A. Cohen, Mark Freedman, et al.. (2015). Rationale for EDSS-Plus, the Primary Composite Endpoint of Disability Progression in the ASCEND Phase 3 Study of Natalizumab for Secondary Progressive Multiple Sclerosis: A Post Hoc Analysis of IMPACT Study Data (P7.240). Neurology. 84(14_supplement). 1 indexed citations

Ranger, Ann, Soma Ray, Suzanne Szak, et al.. (2014). Blocking LINGO-1 Does Not Affect Inflammatory Markers in the Cerebrospinal Fluid of Individuals with Multiple Sclerosis (P1.186). Neurology. 82(10_supplement). 1 indexed citations

Erlanger, David M., Tanya Kaushik, Lauren Caruso, et al.. (2014). Reliability of a cognitive endpoint for use in a multiple sclerosis pharmaceutical trial. Journal of the Neurological Sciences. 340(1-2). 123–129. 29 indexed citations

10.

Brown, Robert A., Stuart D. Cook, Diego Cadavid, et al.. (2013). Effect of Interferon beta-1b and Glatiramer Acetate on New MTR Brain Lesions in MS (P07.104). Neurology. 80(7_supplement). 1 indexed citations

11.

Cadavid, Diego, Leo Wolansky, Joan Skurnick, et al.. (2009). Efficacy of treatment of MS with IFNβ-1b or glatiramer acetate by monthly brain MRI in the BECOME study. Neurology. 72(23). 1976–1983. 132 indexed citations

12.

Cadavid, Diego, et al.. (2009). Understanding tropism and immunopathological mechanisms of relapsing fever spirochaetes. Clinical Microbiology and Infection. 15(5). 415–421. 10 indexed citations

13.

Mehra, Rohit, Diana Londoño, Marie Sondey, Catherine L. Lawson, & Diego Cadavid. (2009). Structure-Function Investigation of Vsp Serotypes of the Spirochete Borrelia hermsii. PLoS ONE. 4(10). e7597–e7597. 15 indexed citations

14.

Cadavid, Diego, Jerry Cheriyan, Joan Skurnick, et al.. (2009). New acute and chronic black holes in patients with multiple sclerosis randomised to interferon beta-1b or glatiramer acetate. Journal of Neurology Neurosurgery & Psychiatry. 80(12). 1337–1343. 34 indexed citations

15.

Londoño, Diana, Adriana Marques, Ronald L. Hornung, & Diego Cadavid. (2008). IL-10 Helps Control Pathogen Load during High-Level Bacteremia. The Journal of Immunology. 181(3). 2076–2083. 27 indexed citations

16.

Gelderblom, Hans, Jens Schmidt, Diana Londoño, et al.. (2007). Role of Interleukin 10 during Persistent Infection with the Relapsing Fever Spirochete Borrelia turicatae. American Journal Of Pathology. 170(1). 251–262. 20 indexed citations

17.

Cadavid, Diego, et al.. (2007). Coinfection withBorrelia turicataeSerotype 2 Prevents the Severe Vestibular Dysfunction and Earlier Mortality Caused by Serotype 1. The Journal of Infectious Diseases. 195(11). 1686–1693. 9 indexed citations

18.

Cadavid, Diego, et al.. (2006). Residual Brain Infection in Relapsing‐Fever Borreliosis. The Journal of Infectious Diseases. 193(10). 1451–1458. 20 indexed citations

19.

Bai, Yunhong, Kavitha Narayan, Donna Dail, et al.. (2004). Spinal cord involvement in the nonhuman primate model of Lyme disease. Laboratory Investigation. 84(2). 160–172. 38 indexed citations

20.

Cadavid, Diego, Hernando Mena, Kelly K. Koeller, & R. Allen Frommelt. (2000). Cerebral Beta Amyloid Angiopathy Is a Risk Factor for Cerebral Ischemic Infarction. A Case Control Study in Human Brain Biopsies. Journal of Neuropathology & Experimental Neurology. 59(9). 768–773. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact